Indivior added to S&P SmallCap 600 index, boosting U.S. business profile

Grafa
Indivior added to S&P SmallCap 600 index, boosting U.S. business profile
Indivior added to S&P SmallCap 600 index, boosting U.S. business profile
Isaac Francis
Written by Isaac Francis
Share

Indivior (NASDAQ:INDV) has announced its inclusion in the S&P SmallCap 600 index, effective December 22, 2025.

The company stated that this milestone aligns its capital markets presence with a sharpened U.S. business profile and supports the growth of SUBLOCADE, its first-in-class long-acting injectable for moderate to severe opioid use disorder.

The S&P SmallCap 600 tracks 600 U.S. small-cap companies with market capitalizations typically ranging between $1.2 billion and $8 billion, with additional liquidity and viability criteria for inclusion.

Indivior's addition to the index reflects its growing influence and potential in the healthcare sector, underscoring its commitment to expanding its U.S. footprint.

Connect with us

Disclaimer

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.